GlassScriptPhysician profile
Heather Ann Haddad
NPI 1609445691
$2,221.56
in general payments reported to CMS, 2019-2025
24 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $309 · 2023: $488 · 2024: $358 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $415.62 | 2021-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $318.26 | 2021-2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $281.31 | 2021-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $188.65 | 2021-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $174.84 | 2022-2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.77 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $121.22 | 2023-2025 | Emblem Mri S-Icd, Dynagen Mini Icd Vr |
| Pfizer INC. | $81.20 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $63.97 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $47.06 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $42.48 | 2024 | Opsumit |
| Scpharmaceuticals INC. | $42.15 | 2025 | |
| Kestra Medical Technology Services, INC. | $37.18 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $30.52 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $28.17 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $23.11 | 2021 | |
| Lantheus Medical Imaging, INC. | $22.36 | 2022 | |
| Philips North America LLC | $21.53 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.53 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $20.08 | 2024 | |
| Bridgebio Pharma, INC. | $18.99 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $18.67 | 2024 | Arcalyst |
| Heartflow, INC. | $16.39 | 2023 | Ffrct |
| Baxter Healthcare | $15.50 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.